Published DateClear

Start Date

End Date

Category

• Business1
• Pipeline1

Organizations

• Bausch + Lomb67
• Eyes On Eyecare53
• Alcon, Inc.47
• American Optometric Association38
• Harrow31
• Glaukos28
• Regeneron25
• Topcon Healthcare25
• Aldeyra Therapeutics21
• Sight Sciences19

Tags

• Gene Therapy2
• FDA1
• Choroideremia1
• Finance1
• Injections1
• Optogenetic1
• Retina1
• Retinitis Pigmentosa1

• Organizations: Ray Therapeutics✕

Clear all

Pipeline

FDA grants RMAT designation to Ray Therapeutics' RP optogenetic therapy

RTx-015 is a single, IVT-administered therapeutic designed to restore vision by converting surviving neurons into photo-sensing cells.

Business

Ray Therapeutics secures $100 million in funding for optogenetic gene therapy programs

Company plans on using funding to target inherited retinal diseases.